As declared before, some well-known investors in China and I set up a buyer consortium (“founder consortium”) and issued a buyout offer to i Kang Healthcare Group, Inc. (“Company” or “i Kang”) on August 31, 2015, and on January 5, 2016 the consortium members were expanded and strengthened. It is well known that the capital market and supervision system in China changed greatly in the past months. Upon full assessment of the market changes, on June 7, 2016, I told the special committee of i Kang that I would withdraw from the founder consortium.

The mission of i Kang is to accelerate the development of preventive medical service in China to improve life quality. In the past over decade of years, under our endeavor, i Kang has become the leading medical service provider in China. During provision of high quality and standard services to customers, it is very important for me, as the founder of i Kang, to do my best to maintain the value and mission of the company. I firmly believed that, it is helpful for i Kang as an independent market participant to promote competition, improve physical examination industrial standard and benefit customers.

As the founder of i Kang, it is a very tough decision. When there come such chances, I hope the company management can support new investors, keep i Kang’s service quality, stick to the value of i Kang and continue the mission of i Kang with new investors.

Zhang Ligang, chairman & CEO of i Kang Healthcare Group, Inc.

June 8, 2016